Navigation Links
PharmAthene Reports Third Quarter 2009 Financial and Operational Results
Date:11/12/2009

comprehensive income 879,759 386,351 Accumulated deficit (150,638,551) (123,817,664) ------------ ------------ Total stockholders' equity 6,486,588 18,963,439 --------- ---------- Total liabilities and stockholders' equity $41,969,842 $56,391,270 =========== ===========
                             PHARMATHENE, INC.
           UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

                            Three months ended            Nine months ended
                               September 30,                 September 30,
                           2009             2008         2009         2008
                           ----             ----         ----         ----

    Contract revenue     $6,830,399    $10,643,705   $20,423,513  $27,377,207
    Other revenue                 -         32,461             -       53,612
                                ---         ------           ---       ------
                          6,830,399     10,676,166    20,423,513   27,430,819
    Operating expenses:
     Research and
      development         7,609,794      9,414,093    22,769,749   26,475,436
     General and
      administrative      6,224,868      4,803,190    15,787,115   14,655,971
     Acquired in-process
      research and
      development                 -        225,000             -   16,131,002
     Depreciation and
      amortization          247,747        205,409       639,924      641,425
     Other expenses         274,005              -     1,158,566            -
                         ----------     ----------    ----------   ----------
     Total operating
      expenses           14,356,414     14,647,692    40,355,354   57,903,834
            
'/>"/>
SOURCE PharmAthene, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. Hearing Scheduled in the Delaware Court of Chancery for August 27, 2007 to Establish the Valid Approval and Consummation of the Merger Between PharmAthene, Inc. and Healthcare Acquisition Corp.
2. Proceedings to Affirm Merger Between PharmAthene and Healthcare Acquisition Corp Initiated in Delaware Chancery Court
3. PharmAthene Named as Contractor in $13.9 Million Award Notice Published by the Department of Health and Human Services
4. Delaware Court Denies Motion by SIGA Technologies Seeking to Dismiss PharmAthenes Legal Action in Breach of Contract Lawsuit Against SIGA
5. PharmAthene to Present at the BIO CEO & Investor Conference 2008
6. PharmAthene Enhances Executive Leadership Team and Appoints Joan Fusco, Ph.D. Senior Vice President of Operations
7. PharmAthene Completes Pharmacokinetic Studies of Protexia(R); Program on Target for IND Filing in 2008
8. PharmAthene to Present at the Cowen and Company 28th Annual Health Care Conference
9. PharmAthene Signs Definitive Agreement to Acquire Biodefense Vaccines Business From Avecia
10. PharmAthene to Delay Release of Full Year 2007 Financial Results
11. PharmAthene Year-End 2007 Earnings Conference Call and Webcast Scheduled for Monday, March 31, 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)... BioConvergence team members Curtis Strother ... 2013’s BioLogistics Summit in San Francisco earlier this ... Chain IQ and IQPC, addressed the increasingly complex ... part, attributed to current trends of globalization, outsourcing, ... trends is an increase in movement, which is ...
(Date:6/19/2013)... Adding to their already extensive supply ... Simport’s Dropette® and Heathrow Scientific disposable plastic ... basic biology, chemistry and any type of liquid handling ... 35 years, Simport has been supplying the science community ... the Simport Dropette®. Simport’s Dropette® is a one-piece ...
(Date:6/18/2013)... Angeles, CA (PRWEB) June 18, 2013 (PRWEB) June ... construction’s #1 time and attendance system in North ... software that shares employee data and payroll records ... AccountLinx Plus automates ExakTime software setup ... The software imports employee data from a business’ ...
(Date:6/18/2013)... 18, 2013 Nasseo, Inc. today announces ... Winner out of hundreds of applicants by the ... Arizona Innovation Challenge . The Arizona Innovation Challenge (AIC) ... technology commercialization challenge, granting a financial award to what ... ventures. Nasseo’s state of the art dental and orthopedic ...
Breaking Biology Technology:BioConvergence® Presents at BioLogistics Summit on Risk Matrix for Biosamples during Shipment 2Leading Pipette Distributor Pipette.com Now Stocks Transfer Pipettes: Simport’s Dropette and Heathrow Scientific Disposable Plastic Transfer Pipettes 2ExakTime Introduces AccountLinx Plus 2Nasseo Named 2013 Innovation Challenge Winner by Arizona Commerce Authority 2
... Pharma, an emerging biotech,company focused on developing ... data demonstrating that its enzyme,replacement therapy (ERT) ... already been severely weakened by the disease. ... product ENB-0040, significantly,increases survival and prevents bone ...
... Commentary and How-To, Communications Tools; and ... ALTO, Calif., Sept. 15 Lena Chow, a ... has,launched a new website, http://www.cityofparis.us, to ... share thinking, gain insights and,connect with their peers. ...
... SHENYANG, China, Sept. 15 3SBio Inc. (Nasdaq:,SSRX), ... manufacturing and marketing biopharmaceutical products, today,announced the results ... General,Meeting of Shareholders held on September 12, 2008 ... meeting, the Company,s shareholders re-elected Dr. Jing Lou,Liping ...
Cached Biology Technology:Enobia Pharma Presents PreClinical Data Showing ENB-0040 Significantly Improved Survival and Healed Skeletal Manifestations of Severe Hypophosphatasia in Mice 2Enobia Pharma Presents PreClinical Data Showing ENB-0040 Significantly Improved Survival and Healed Skeletal Manifestations of Severe Hypophosphatasia in Mice 3
(Date:6/18/2013)... a very large "dead zone" in the Gulf of ... the Chesapeake Bay this year, based on several NOAA-supported ... Michigan, Louisiana State University, and the Louisiana Universities ... Mexico hypoxic "dead" zone will be between 7,286 and ... ten largest recorded. That would range from an area ...
(Date:6/18/2013)... The National Institutes of Health has awarded $12.7 ... a selection of pharmaceutical industry compounds to explore ... including Alzheimer,s disease, Duchenne muscular dystrophy and schizophrenia. ... Uses for Existing Molecules, is led by the ... funded by the NIH Common Fund. , The ...
(Date:6/18/2013)... for Molecular Pathology is proud to announce it will ... (FASEB) on July 1, 2013. The FASEB Board approved ... , The 26 constituent societies of FASEB represent more ... the advancement of research and education in biological and ... important now than ever," said Jennifer L. Hunt, MD, ...
Breaking Biology News(10 mins):NOAA, partners predict possible record-setting deadzone for Gulf of Mexico 2NOAA, partners predict possible record-setting deadzone for Gulf of Mexico 3NOAA, partners predict possible record-setting deadzone for Gulf of Mexico 4NIH to fund collaborations with industry to identify new uses for existing compounds 2NIH to fund collaborations with industry to identify new uses for existing compounds 3NIH to fund collaborations with industry to identify new uses for existing compounds 4
... to predict the impact of climate change on the dengue ... that could help limit its spread. According to ... Ecological Society,s journal Functional Ecology , climate change and ... mosquito,s range. But human behaviour in the form of ...
... 2009. The Alfred Wegener Institute for Polar and ... the ongoing Polarstern expedition LOHAFEX". Independent scientific and ... Education and Research and the Federal Ministry for ... that the iron fertilisation experiment LOHAFEX is neither ...
... leading provider of,embedded speech solutions today announced the ... AG, according to SVOX CEO Volker Jantzen.,SVOX has ... developed,over 25 years, including the SpeechAdvance(TM) speech recognition ... majority of the Professional,Speech Processing Group,s employees will ...
Cached Biology News:Hoarding rainwater could 'dramatically' expand range of dengue-fever mosquito 2Polarstern expedition 'LOHAFEX' can be conducted 2Polarstern expedition 'LOHAFEX' can be conducted 3SVOX Acquires Speech Processing Unit of Siemens AG, Expands Into Speech Recognition and Speech Dialog 2
... derived from Paraffin embedded tissue blocks, which ... to ensure the highest quality. Tissues of ... block, sectioned at a thickness of 5 ... are large (3-5 mm in diameter) in ...
... Zyagen tissue microarrays are derived from ... to rigorous quality control procedures to ensure ... are manually assembled in one block, sectioned ... on coated slides. Sections are large (3-5mm ...
... microarrays are derived from Paraffin embedded tissue ... control procedures to ensure the highest quality. ... in one block, sectioned at a thickness ... slides. Sections are large (3-5mm in diameter) ...
... Microdissection , CapSure HS and CapSure Macro ... extraction of populations of pure cells from ... Capture Microdissection., Ensure the Integrity of ... All CapSure LCM Caps have a patented ...
Biology Products: